Thin film nitinol microstent for aneurysm occlusion

In Vitro Investigation of a New Thin Film Nitinol-Based Neurovascular Flow Diverter

Fusiform and wide-neck cerebral aneurysms (CAs) can be challenging to treat with conventional endovascular or surgical approaches. Recently, flow diverters have been developed to treat these cases by diverting flow away from the aneurysm rather than occluding it. The pipeline embolization device (PED), which embodies a single-layer braided design, is best known among available flow diverters. While the device has demonstrated success in recent trials, late aneurysmal rupture after PED treatment has been a concern. More recently, a new generation of dual-layer devices has emerged that includes a novel hyperelastic thin film nitinol (HE-TFN)-covered design. In this study, we compare fluid dynamic performance between the PED and HE-TFN devices using particle image velocimetry (PIV). The PED has a pore density of 12.5–20 pores/mm2 and a porosity of 65–70%. The two HE-TFN flow diverters have pore densities of 14.75 pores/mm2 and 40 pores/mm2, and porosities of 82% and 77%, respectively. Conventional wisdom suggests that the lower porosity PED would decrease intra-aneurysmal flow to the greatest degree. However, under physiologically realistic pulsatile flow conditions, average drops in root-mean-square (RMS) velocity (VRMS) within the aneurysm of an idealized physical flow model were 42.8–73.7% for the PED and 68.9–82.7% for the HE-TFN device with the highest pore density. Interestingly, examination of collateral vessel flows in the same model also showed that the HE-TFN design allowed for greater collateral perfusion than the PED. Similar trends were observed under steady flow conditions in the idealized model. In a more clinically realistic scenario wherein an anatomical aneurysm model was investigated, the PED affected intra-aneurysmal VRMS reductions of 64.3% and 56.3% under steady and pulsatile flow conditions, respectively. In comparison, the high pore density HE-TFN device reduced intra-aneurysmal VRMS by 88% and 71.3% under steady and pulsatile flow conditions, respectively. We attribute the superior performance of the HE-TFN device to higher pore density, which may play a more important role in modifying aneurysmal fluid dynamics than the conventional flow diverter design parameter of greatest general interest, absolute porosity. Finally, the PED led to more elevated intra-aneurysmal pressures after deployment, which provides insight into a potential mechanism for late rupture following treatment with the device.

A novel low-profile thin-film nitinol/silk endograft for treating small vascular diseases

Since the introduction of various endovascular graft materials such as expanded polytetrafluoroethylene (e-PTFE) and Dacron^® polyester, they have been rapidly applied in endovascular devices for treating a variety of clinical situations. While present endovascular grafts have been successful in treating large blood vessels, there are still significant challenges and limitations for small and tortuous vessels to their use. Recently, our group has demonstrated the potential to use thin-film nitinol (TFN) as a novel material to develop endografts used in the treatment of a wide range of small vascular diseases because TFN is ultralow profile (that is, a few micrometers thick), relatively thromboresistant, and superelastic. While TFN has shown superior thromboresistance, its surface endothelialization is not rapid and sufficient. Therefore, our laboratory has been exploring the feasibility of using thin-film silk as a novel coating for facilitating rapid and confluent endothelial cell growth. The purpose of this study is to fabricate a low-profile composite endograft using thin layers of nitinol and silk, and to evaluate both thrombogenicity as well as endothelial cell and smooth muscle cell responses. This study also evaluates the functionality of the composite endograft using an in vitro blood circulation model. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 575-584, 2017.

An overview of thin film nitinol endovascular devices

Thin film nitinol has unique mechanical properties (e.g., superelasticity), excellent biocompatibility, and ultra-smooth surface, as well as shape memory behavior. All these features along with its low-profile physical dimension (i.e., a few micrometers thick) make this material an ideal candidate in developing low-profile medical devices (e.g., endovascular devices). Thin film nitinol-based devices can be collapsed and inserted in remarkably smaller diameter catheters for a wide range of catheter-based procedures; therefore, it can be easily delivered through highly tortuous or narrow vascular system. A high-quality thin film nitinol can be fabricated by vacuum sputter deposition technique. Micromachining techniques were used to create micro patterns on the thin film nitinol to provide fenestrations for nutrition and oxygen transport and to increase the device's flexibility for the devices used as thin film nitinol covered stent. In addition, a new surface treatment method has been developed for improving the hemocompatibility of thin film nitinol when it is used as a graft material in endovascular devices. Both in vitro and in vivo test data demonstrated a superior hemocompatibility of the thin film nitinol when compared with commercially available endovascular graft materials such as ePTFE or Dacron polyester. Promising features like these have motivated the development of thin film nitinol as a novel biomaterial for creating endovascular devices such as stent grafts, neurovascular flow diverters, and heart valves. This review focuses on thin film nitinol fabrication processes, mechanical and biological properties of the material, as well as current and potential thin film nitinol medical applications.

Smart Guidewires for Smooth Navigation in Neurovascular Intervention

Smart nitinol guidewires have been proposed to improve trackability, facilitating the advancement of catheters through complex vascular anatomies during neurovascular interventions. A smart 0.015 in. diameter nitinol guidewire was actualized through Joule heating of one-way and two-way shape memory alloys (SMA). The device functionalities in terms of bending performance were analyzed: (1) trackability of a 4 Fr catheter as determined in an anatomically correct in vitro environment; (2) time and spatial response of the smart guidewire as a function of material temperature and applied current; and (3) thrombogenic effects as a function of temperature and applied voltage. The results suggest that smart guidewires have substantially improved trackability (i.e., deflection of 15 deg) to overcome the “ledge effect” with the absence of thrombogenicity via a smart guidewire–catheter combined transcatheter based procedure which keeps the catheter surface temperature at 30–33 °C.

Evaluation of magnetic resonance imaging issues for implantable microfabricated magnetic actuators

The mechanical robustness of microfabricated torsional magnetic actuators in withstanding the strong static fields (7 T) and time-varying field gradients (17 T/m) produced by an MR system was studied in this investigation. The static and dynamic mechanical characteristics of 30 devices were quantitatively measured before and after exposure to both strong uniform and non-uniform magnetic fields. The results showed no statistically significant change in both the static and dynamic mechanical performance, which mitigate concerns about the mechanical stability of these devices in association with MR systems under the conditions used for this assessment. The MR-induced heating was also measured in a 3-T/128-MHz MR system. The results showed a minimal increase (1.6 °C) in temperature due to the presence of the magnetic microactuator array. Finally, the size of the MR-image artifacts created by the magnetic microdevices were quantified. The signal loss caused by the devices was approximately four times greater than the size of the device.

In vitro and in vivo testing of a novel, hyperelastic thin film nitinol flow diversion stent

A flexible, low profile, flow diversion stent could replace endovascular coiling for the treatment of intracranial aneurysms. Micropatterned-thin film nitinol (TFN) is a novel biomaterial with high potential for use in next-generation endovascular devices. Recent advancements in micropatterning have allowed for fabrication of a hyperelastic thin film nitinol (HE-TFN). In this study, the authors describe in vitro and in vivo testing of novel HE-TFN based flow diverting stents. Two types of HE-TFN with expanded pores having long axes of 300 and 500 μm were used to fabricate devices. In vitro examination of the early thrombotic response in whole blood showed a possible mechanism for the device's function, whereby HE-TFN serves as a scaffold for blood product deposition. In vivo testing in swine demonstrated rapid occlusion of model wide-neck aneurysms. Average time to occlusion for the 300-μm device was 10.4 ± 5.5 min. (N = 5) and 68 ± 30 min for the 500-μm device (N = 5). All aneurysms treated with bare metal control stents remained patent after 240 min (N = 3). SEM of acutely harvested devices supported in vitro results, demonstrating that HE-TFN serves as a scaffold for blood product deposition, potentially enhancing its flow-diverting effect. Histopathology of devices after 42 days in vivo demonstrated a healthy neointima and endothelialization of the aneurysm neck region. HE-TFN flow-diverting stents warrant further investigation as a novel treatment for intracranial aneurysms.